30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
Sweden Pharmaceuticals

Elicera Therapeutics AB (ELIC)

Track

Stock chart
Ticker: ELIC Exchange: STO
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Jamal El Mosleh
Chief Executive Officer (CEO)/Managing Directory
1 sale — total 131,800 SEK
Sale 27 May 2025
Value SEK1,530,079.23 | Price 158.57 | Shares 36,426
Sale 26 May 2025
Value SEK4,185,550.55 | Price 251.17 | Shares 65,074
Sale 23 May 2025
Value SEK667,275.00 | Price 6.51 | Shares 102,500
Sale 22 May 2025
Value SEK1,496,250.00 | Price 6.30 | Shares 237,500
Buy 11 Mar 2025
Value SEK40,145.00 | Price 1.85 | Shares 21,700
Buy 11 Mar 2025
Value SEK79,940.35 | Price 1.85 | Shares 43,211
Buy 11 Mar 2025
Value SEK49,999.95 | Price 1.85 | Shares 27,027
Buy 11 Mar 2025
Value SEK40,145.00 | Price 1.85 | Shares 21,700
Buy 11 Mar 2025
Value SEK92,500.00 | Price 1.85 | Shares 50,000
Buy 11 Mar 2025
Value SEK281,015.00 | Price 1.85 | Shares 151,900
Buy 11 Mar 2025
Value SEK95,460.00 | Price 1.85 | Shares 51,600
Buy 10 Mar 2025
Value SEK9,000.00 | Price 0.50 | Shares 18,000
Buy 25 Apr 2024
Value SEK50,000.00 | Price 1.00 | Shares 50,000
Buy 20 Mar 2024
Value SEK3,439,360.00 | Price 1.28 | Shares 2,687,000
Sale 20 Mar 2024
Value SEK3,439,360.00 | Price 1.28 | Shares 2,687,000
Buy 8 Mar 2024
Value SEK73,191.60 | Price 16.20 | Shares 4,518
Buy 8 Mar 2024
Value SEK50,220.00 | Price 16.20 | Shares 3,100
Buy 8 Mar 2024
Value SEK351,540.00 | Price 16.20 | Shares 21,700
Buy 8 Mar 2024
Value SEK50,220.00 | Price 16.20 | Shares 3,100
Buy 8 Mar 2024
Value SEK69,660.00 | Price 16.20 | Shares 4,300
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-05-27 2025-05-27 S Sale
3.4
Jamal El Mosleh

Chief Executive Officer (CEO)/Managing Directory

Officer
36,426
158.57
SEK1,530,079 		36,426 158.57 SEK1,530,079
2025-05-27 2025-05-26 S Sale
3.4
Jamal El Mosleh

Chief Executive Officer (CEO)/Managing Directory

Officer
65,074
251.17
SEK4,185,551 		65,074 251.17 SEK4,185,551
2025-05-27 2025-05-23 S Sale
3.4
Jamal El Mosleh

Chief Executive Officer (CEO)/Managing Directory

Officer
54,823
68.06
SEK123,511 		54,823 68.06 SEK123,511
2025-05-27 2025-05-22 S Sale
3.4
Jamal El Mosleh

Chief Executive Officer (CEO)/Managing Directory

Officer
237,500
6.30
SEK1,496,250 		237,500 6.30 SEK1,496,250
2025-03-12 2025-03-11 B Purchase
3.5
Margareth Jorvid

Member of the Board of Directors

Director
21,700
1.85
SEK40,145 		21,700 1.85 SEK40,145
2025-03-12 2025-03-11 B Purchase
3.3
Magnus Essand

Member of the Board of Directors

Director
43,211
1.85
SEK79,940 		43,211 1.85 SEK79,940
2025-03-12 2025-03-11 B Purchase
3.3
Agneta Edberg

Chairman of the Board of Directors

Director
27,027
1.85
SEK50,000 		27,027 1.85 SEK50,000
2025-03-12 2025-03-11 B Purchase
1.4
Christina Herder

Member of the Board of Directors

Director
21,700
1.85
SEK40,145 		21,700 1.85 SEK40,145
2025-03-11 2025-03-11 B Purchase
3.3
Di Yu

Deputy Member of the Board of Directors

Director
50,000
1.85
SEK92,500 		50,000 1.85 SEK92,500
2025-03-11 2025-03-11 B Purchase
3.4
Jamal El Mosleh

Chief Executive Officer (CEO)/Managing Directory

Officer
151,900
1.85
SEK281,015 		151,900 1.85 SEK281,015
2025-03-11 2025-03-11 B Purchase
3.3
Rolf Ingvar Lennart Karlsson

Chief Financial Officer (CFO)

Officer
51,600
1.85
SEK95,460 		51,600 1.85 SEK95,460
2025-03-11 2025-03-10 B Purchase
3.3
Rolf Ingvar Lennart Karlsson

Chief Financial Officer (CFO)

Officer
18,000
0.50
SEK9,000 		18,000 0.50 SEK9,000
2024-04-26 2024-04-25 B Purchase
3.4
Jamal El Mosleh

Chief Executive Officer (CEO)/Managing Directory

Officer
50,000
1.00
SEK50,000 		50,000 1.00 SEK50,000
2024-03-21 2024-03-20 B Purchase
3.4
Jamal El Mosleh

Chief Executive Officer (CEO)/Managing Directory

Officer
2,687,000
1.28
SEK3,439,360 		2,687,000 1.28 SEK3,439,360
2024-03-21 2024-03-20 S Sale
3.4
Jamal El Mosleh

Chief Executive Officer (CEO)/Managing Directory

Officer
2,687,000
1.28
SEK3,439,360 		2,687,000 1.28 SEK3,439,360
2024-03-11 2024-03-08 B Purchase
3.3
Agneta Edberg

Chairman of the Board of Directors

Director
4,518
16.20
SEK73,192 		4,518 16.20 SEK73,192
2024-03-10 2024-03-08 B Purchase
3.5
Margareth Jorvid

Member of the Board of Directors

Director
3,100
16.20
SEK50,220 		3,100 16.20 SEK50,220
2024-03-09 2024-03-08 B Purchase
3.4
Jamal El Mosleh

Chief Executive Officer (CEO)/Managing Directory

Officer
21,700
16.20
SEK351,540 		21,700 16.20 SEK351,540
2024-03-09 2024-03-08 B Purchase
1.4
Christina Herder

Member of the Board of Directors

Director
3,100
16.20
SEK50,220 		3,100 16.20 SEK50,220
2024-03-09 2024-03-08 B Purchase
3.3
Jan Zetterberg

Member of the Board of Directors

Director
4,300
16.20
SEK69,660 		4,300 16.20 SEK69,660
Explore more

More insider trading research around Elicera Therapeutics AB

More insider trades in Sweden
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in Europe